Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe.

Slides:

Advertisements

Similar presentations

Hollie Shaner-McRae DNP RN FAAN

Advertisements

VTE Prophylaxis in the Hospitalized Patient: Importance and Strategies for Improved Compliance Andrew H. Dombro, M.D. Instructor of Medicine Division of.

Risk stratification and incidence of acute complications in upper extremity deep vein thrombosis (UEDVT) patients. Dr. Santosh Yatam Ganesh MBBS, MPH.,

Preventing VTE in Surgical Patients. Today’s Topics The common sense science of VTE prevention Brief history of VTE prevention techniques High yield methods.

LHD Logo Venous Thromboembolism Reducing the Risk DATE.

Thromboembolic complications in IBD

Optimizing Venous Thromboembolism Prophylaxis using Physician Order Entry: Johns Hopkins Hospital Experience Michael B. Streiff, MD Associate Professor.

Deep Vein Thrombosis and Pulmonary Embolism prophylaxis in Asian general surgical patients: is it necessary?  AMY KOK Caritas Medical Centre.

+ Deep Vein Thrombosis Common, Preventable, and potentially Fatal.

Results: 1.Progression of thrombus length and volume (40% vs. 28%; P

Venous Thromboembolism Prevention August Venous Thromboembloism Prevention 2 Expected Practice  Assess all patients upon admission to the ICU for.

Prophylaxis of Venous Thromboembolism

Venous Thromboembolism (VTE) Prophylaxis Policy Mary-Anne Davies Patient Safety Specialist Accreditation Coordinator.

Venous Thromboembolism

Deep Vein Thrombosis (DVT)

RecommendationsRecommendations Risk Recommendation Ambulation (all pts) IPC/GCS or, UFH 5000 SQ q 12 hrs or, Enoxaparin 40mg SQ daily IPC/GCS or, UFH 5000.

QAH HospitalPortsmouth Hospitals NHS Trust Venous Thromboembolism Patient Safety Study Day Simon Freathy.

Consistent Venous Thromboembolism Risk Reduction by Extended- Versus Standard-Duration Enoxaparin Prophylaxis in Subgroups of Acutely Ill Medical Patients.

 When untreated, general postsurgical patients risk for Deep Venous Thrombosis (DVT) is 19%-25% (Buckner, et al., 2013).  Post surgical orthopedic patients.

Chapter Two Venous Disease Coalition Pathogenesis and Consequences of VTE VTE Toolkit.

Chapter Three Venous Disease Coalition Epidemiology of VTE Risks, Risk Factors VTE Toolkit.

2007 Deep Vein Thrombosis (DVT) Awareness Program

Medical Patients – VTE Prevention Dale W. Bratzler, DO, MPH Professor and Associate Dean, College of Public Health Professor of Medicine, College of Medicine.

What You Need to Know about Blood Clots. What You Need to Know About Blood Clots or Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)

Prevention Of Venous Thromboembolism In The Cancer Surgical Patient A K Kakkar Barts and the London School of Medicine and Thrombosis Research Institute,

Spotlight Case May 2003 Central Line Complications in an Infant webmm.ahrq.gov.

Prevention of Venous Thromboembolism 8 th ACCP Guidelines Chest 2008.

The Role of Thromboprophylaxis in Elective Spinal Surgery The Role of Thromboprophylaxis in Elective Spinal Surgery VA Elwell, N Koo Ng, D Horner & D Peterson.

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,

VTE Venous ThromboEmbolism. VTE – aims of this module To define the terms associated with VTE and offer maximum care to treat patients. To define the.

Rivaroxaban for Prevention of Venous Thromboembolism After Total Knee Arthroplasty: Impact on Healthcare Costs Based on the RECORD3 Study Kwong L, Lees.

VTE prevention and anticoagulation practice VTE prevention and anticoagulation practice Mr A McSorley Lead Thrombosis Nurse RCHT.

Thromboprophylaxis in the paediatric setting. Background No evidence for routine VTE risk assessment No evidence to support the routine use of thromboprophylaxis,

Venous Thromboembolic Disease After Total Hip and Knee Arthroplasty by Steven B. Haas, Robert L. Barrack, Geoffrey Westrich, and Paul F. Lachiewicz J Bone.

Venous Thromboembolism Prophylaxis for Medical Inpatients Heather Hofmann, rev. 4/18/14 DSR2 Mini Lecture.

Respiratory CONNECT meeting Dr Julius Cairn. Risk stratification in PE Clinical parameters – shock, JVP, S3 Imaging – CTPA, echo Biomarkers – Troponin,

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, General Medicine,

The Prevalence of and Specific Risk Factors for Venous Thromboembolic Disease Following Elective Spine Surgery by Jason M. Sansone, Alejandro Munoz del.

Risk Assessment for VTE. Which of the following best describes you?

Prophylaxis Diagnosis Treatment Venous Thromboembolism Management.

Higher Incidence of Venous Thromboembolism (VTE) in the Outpatient versus Inpatient Setting Among Patients with Cancer in the United States Khorana A et.

Dalteparin in the prevention of venous thromboembolism Odofin Olufemi.

Surgical Care Improvement Project Prevention of Post-operative Venous Thromboembolism Team Membership Department of Surgery, Nursing, Pharmacy, CCE Confidential:

Regulation of Coagulation in Orthopedic Surgery to Prevent Deep Venous Thrombosis and Pulmonary Embolism 1 (RECORD 1 ) Journal Club General Surgery Rotation.

Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.

 Deep Vein Thrombosis Josh Vrona, Hunter Dolan, Erin McCann.

Deep vein thrombosis and pulmonary embolism.

Effect of Post-Discharge Venous Thromboembolism on Hospital Quality Comparisons Following Hip and Knee Arthroplasty by Benjamin S. Kester, Ryan P. Merkow,

Oral Rivaroxaban Compared with Subcutaneous Enoxaparin for Extended Thromboprophylaxis After Total Hip Arthroplasty: The RECORD1 Trial Eriksson BI, Borris.

VTE is a Disease of Hospitalized and Recently Hospitalized Patients Hospitalized patients Community residents Recently hospitalized Heit.

Venous Thromboembolism (VTE) Etiology, Prevention, Recognition, and Treatment 1.

Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Venous Thromboembolism Prophylaxis in Pediatric Patients With Central Venous.

Use of Bevacizumab in anticoagulated recurrent glioblastoma multiforme patients: An Australian experience Adrian Lee 1,2,3,4, Marina Kastelan 4,5, Helen.

Fundamental Research in Oncology & Thrombosis FRONTLINE 1 Survey.

Maile Parker, MSIV University of Washington School of Medicine Sept. 27, 2012 Prevention of Venous Thromboembolism and Catheter Occlusion in Pediatric.

Outpatient DVT assessment & treatment Daniel Gilada.

What Is Deep Vein Thrombosis (DVT)? DVT is a blood clot that forms in a vein deep in the body Most often occurs in the deep veins of the legs, either.

Venous Thromboembolism Prophylaxis for Medical Inpatients

Clinical Professor in Palliative Medicine

Venous Thromboembolism Prophylaxis (VTE)

UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER

Dr.H.Chandrashekar, Dr.A.Chaudhuri, Dr. A. Douglas, Dr. D. Lowdon

UNDERSTANDING YOUR RISK FOR DEVELOPING BLOOD CLOTS (VTE) IN CANCER

NOACs for Cancer-Associated Thrombosis:

The Burden of Hospital-Associated Venous Thromboembolism

Thrombosis in sickle cell

New Oral Anticoagulants and VTE Management

Venous Thromboembolism with Chronic Liver Disease

Variation in thromboembolic complications among patients undergoing commonly performed cancer operations Randall R. De Martino, MD, MS, Philip P. Goodney,

Presentation transcript:

Venous Thromboembolic (VTE) Prophylaxis in Pediatric Trauma Patients Bowe

Outline: Venous thromboembolism -- Adult population Venous thromboembolism -- Peds population Trauma population Chest guidelines

VTE: hospitalized adult population Geerts et al. Chest 2004

VTE: hospitalized adult population Risk Factors: -Central venous lines -Immobility -Malignancy -Major surgery -Medical illness -Sepsis -Trauma Complications: -Death -- 10% of all hospital deaths -Embolism -- PE, stroke -Clot burden/progression -- SVC syndrome -Recurrence -Post-thrombotic syndrome

VTE: pediatric population -Canadian Registry of Venous Thromboembolic Complications -- first analysis 1994

VTE: pediatric population Incidence: -Hospitalized population 5.3 per General population 0.7 per * CVL associated w/20% of all VTEs

VTE: pediatric trauma ,078 pediatric trauma patients -- PHIS database -Age 0-18yrs -Identified those diagnosed with DVT or PE -Identified enoxaparin use via pharmacy codes

VTE: pediatric trauma Associated w/increased use of enoxaparin: -CVL -Pelvic or long bone fx -ICU length of stay -Level 1 trauma designation Associated w/increased VTE: -CVL -Pelvic fx -ICU length of stay

VTE: pediatric trauma

VTE: other populations -Central venous catheter use -Inflammatory bowel disease -Inherited coagulopathy -Malignancy -Orthopedic population

Sources: Andrew M, David M, Adams M, et al. Venous thromboembolic complications in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83: Askgard-Giesmann, O’Brien SH, Kenney BD. Increased use of enoxaparin in pediatric trauma patients. Journal of Pediatric Surgery 2012; 47:980-3 Azu MC, Lee TK. Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary? J Trauma 2005; David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993; 123: Guy Y. New anticoagulants in children: A review of recent studies and a look to the future. Thrombosis research 2010; Moreno, PL. The ICU Book. Venous thromboembolism. 2007; Truitt AK, Sorrells DL, Halvorson E, Luks FI, et al. Pulmonary embolism: which pediatric trauma patients are at risk? J Pediatr Surg 2005; Vavilala MS, Nathens AB, Jurkovich GJ, et al. Risk factors for venous thromboembolism in pediatric trauma. J Trauma 2002;52:922-7.